Two proteins––sIL‐6R (OR = 2.30, 95% CI: 1.22–4.36) and sTNFR2 (OR = 2.08, 95% CI: 1.03–4.18)––showed stronger association with GBM risk (Table S4). Here, IL6R is linked to glioblastoma.